Anti-human adenocarcinoma antigen  monoclonal antibody

Pre-made anti-human adenocarcinoma antigen  monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to human adenocarcinoma antigen / products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-INN082-Ab-1/ GM-Tg-hg-INN082-Ab-2Anti-Human human adenocarcinoma antigen  monoclonal antibodyHuman
GM-Tg-rg-INN082-Ab-1/ GM-Tg-rg-INN082-Ab-2Anti-Rat human adenocarcinoma antigen  monoclonal antibodyRat
GM-Tg-mg-INN082-Ab-1/ GM-Tg-mg-INN082-Ab-2Anti-Mouse human adenocarcinoma antigen  monoclonal antibodyMouse
GM-Tg-cynog-INN082-Ab-1/ GM-Tg-cynog-INN082-Ab-2Anti-Cynomolgus/ Rhesus macaque human adenocarcinoma antigen  monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-INN082-Ab-1/ GM-Tg-felg-INN082-Ab-2Anti-Feline human adenocarcinoma antigen  monoclonal antibodyFeline
GM-Tg-cang-INN082-Ab-1/ GM-Tg-cang-INN082-Ab-2Anti-Canine human adenocarcinoma antigen  monoclonal antibodyCanine
GM-Tg-bovg-INN082-Ab-1/ GM-Tg-bovg-INN082-Ab-2Anti-Bovine human adenocarcinoma antigen  monoclonal antibodyBovine
GM-Tg-equg-INN082-Ab-1/ GM-Tg-equg-INN082-Ab-2Anti-Equine human adenocarcinoma antigen  monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-INN082-Ab-1/ GM-Tg-hg-INN082-Ab-2; GM-Tg-rg-INN082-Ab-1/ GM-Tg-rg-INN082-Ab-2;
GM-Tg-mg-INN082-Ab-1/ GM-Tg-mg-INN082-Ab-2; GM-Tg-cynog-INN082-Ab-1/ GM-Tg-cynog-INN082-Ab-2;
GM-Tg-felg-INN082-Ab-1/ GM-Tg-felg-INN082-Ab-2; GM-Tg-cang-INN082-Ab-1/ GM-Tg-cang-INN082-Ab-2;
GM-Tg-bovg-INN082-Ab-1/ GM-Tg-bovg-INN082-Ab-2; GM-Tg-equg-INN082-Ab-1/ GM-Tg-equg-INN082-Ab-2
Products NameAnti-human adenocarcinoma antigen  monoclonal antibody
Formatmab
Target Namehuman adenocarcinoma antigen 
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-human adenocarcinoma antigen  monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-1013Pre-Made Technetium (99Mtc) Pintumomab Biosimilar, Radiolabelled Antibody: Anti-Human Adenocarcinoma Antigen therapeutic antibody
    Target AntigenGM-Tg-g-INN082-Ag-1Recombinant multi-species human adenocarcinoma antigen  protein


    Target information

    Target IDGM-INN082
    Target Namehuman adenocarcinoma antigen?
    Gene IDN/A
    Gene Symbol and Synonyms
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, INN Index
    DiseaseN/A
    Gene EnsemblN/A
    Target ClassificationN/A

    The target: human adenocarcinoma antigen , gene name: , also named as . .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.